Sermorelin is a synthetic analog of growth hormone–releasing hormone (GHRH) that is frequently studied in endocrine research, including investigations related to women’s health and hormonal regulation. In laboratory settings, scientists examine how Sermorelin interacts with the hypothalamic–pituitary axis to influence growth hormone signaling patterns, metabolic balance, and physiological adaptation across different life stages.